Position in NEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,046,220
-$4,936,750 QoQ
Shares Held
275,771
-53.6% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $196,144,169 across 4 Diagnostics & Research names.
All Filings in NEO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,046,220 | 275,771 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,982,970 | 593,790 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,533,196 | 1,234,870 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,703,263 | 1,053,798 | Shares | Sole | 2025-08-14 | |
| 2023-09-30 | $519,219 | 42,213 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,056,775 | 252,444 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,756,211 | 388,065 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,253,079 | 460,290 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,716,024 | 663,882 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,830,598 | 1,083,509 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,790,987 | 558,929 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $2,326,300 | 51,501 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $210,861 | 4,372 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,051,549 | 19,531 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,057,848 | 82,891 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $382,107 | 12,334 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,391,446 | 122,834 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||